Characteristic | Total (n = 141) | Intervention (n = 71) | Control (n = 70) | P-value | |||
---|---|---|---|---|---|---|---|
N | (%) | n | (%) | n | (%) | ||
Age - Mean (SD), yb | 68.9 | (7.35) | 68.9 | (7.78) | 68.8 | (6.96) | 0.963 |
Gendera | |||||||
 Male | 22 | (15.6) | 12 | (16.9) | 10 | (14.3) | 0.669 |
 Female | 119 | (84.4) | 59 | (83.1) | 60 | (85.7) |  |
Body mass index - Mean (SD), kg/m2b | 25.2 | (3.48) | 25.0 | (3.45) | 25.4 | (3.51) | 0.565 |
Symptom duration - Mean (SD), y | 6.4 | (8.52) | 6.7 | (9.39) | 6.0 | (7.60) | 0.664 |
Level of educationa | Â | Â | Â | Â | Â | Â | 0.524 |
 Primary school or less | 22 | (15.6) | 12 | (16.9) | 10 | (14.3) |  |
 Junior high school | 48 | (34.0) | 25 | (35.2) | 23 | (32.9) |  |
 High school | 31 | (22.0) | 12 | (16.9) | 19 | (27.1) |  |
 College graduate and above | 40 | (28.4) | 22 | (31.0) | 18 | (25.7) |  |
Marital statusa | Â | Â | Â | Â | Â | Â | 0.669 |
 Single | 22 | (15.6) | 12 | (16.9) | 10 | (14.3) |  |
 Married | 119 | (84.4) | 59 | (83.1) | 60 | (85.7) |  |
Number of affected knees a | Â | Â | Â | Â | Â | Â | 0.207 |
 One | 63 | (44.7) | 28 | (39.4) | 35 | (50.0) |  |
 Two | 78 | (55.3) | 43 | (60.6) | 35 | (50.0) |  |
Uses a walkera | Â | Â | Â | Â | Â | Â | 0.637 |
 Yes | 5 | (3.5) | 2 | (2.8) | 3 | (4.3) |  |
 No | 136 | (96.5) | 69 | (97.2) | 67 | (95.7) |  |
Comorbid conditionsa | |||||||
 Hypertension |  |  |  |  |  |  | 0.553 |
  Yes | 68 | (48.2) | 36 | (50.7) | 32 | (45.7) |  |
  No | 73 | (51.8) | 35 | (49.3) | 38 | (54.3) |  |
 Diabetes |  |  |  |  |  |  | 0.560 |
  Yes | 29 | (20.6) | 16 | (22.5) | 13 | (18.6) |  |
  No | 112 | (79.4) | 55 | (77.5) | 57 | (81.4) |  |
 Coronary heart disease |  |  |  |  |  |  | 0.743 |
  Yes | 38 | (27.0) | 20 | (28.2) | 18 | (25.7) |  |
  No | 103 | (73.0) | 51 | (71.8) | 52 | (74.3) |  |
 Osteoporosis |  |  |  |  |  |  | 0.105 |
  Yes | 21 | (14.9) | 14 | (19.7) | 7 | (10.0) |  |
  No | 120 | (85.1) | 57 | (80.3) | 63 | (90.0) |  |
Current drug use | |||||||
 Analgesics |  |  |  |  |  |  | 0.654 |
  Yes | 32 | (22.7) | 15 | (21.1) | 17 | (24.3) |  |
  No | 109 | (77.3) | 56 | (78.9) | 53 | (75.7) |  |
 Cartilage protection drugs |  |  |  |  |  |  | 0.067 |
  Yes | 29 | (20.6) | 19 | (26.8) | 10 | (14.3) |  |
  No | 112 | (79.4) | 52 | (73.2) | 60 | (85.7) |  |